The Company repurchased 28.7 million common shares under its previous NCIB effective between February 1, 2023 and January 31, 2024, which allowed for the repurchase of up to 32.0 million common shares.
CN | 2024 Quarterly Review – Third Quarter 19
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
Three months ended September 30
Nine months ended September 30
In millions, except per share data
2024
2023
2024
2023
Number of common shares repurchased
2.5
7.7
14.4
21.8
Weighted-average price per share (1)
$
165.40
$
153.92
$
172.96
$
157.41
Amount of repurchase (1)(2)
$
427
$
1,196
$
2,498
$
3,438
(1)Includes brokerage fees and tax on share repurchases.
(1)The grant date fair value of equity settled DSU awards granted in 2024 of $4 million is calculated using the Company's stock price on the grant date. As at September 30, 2024, the aggregate intrinsic value of all equity settled DSU awards outstanding amounted to $51 million.
(2)For the nine months ended September 30, 2024, the Company purchased common shares for the settlement of equity settled DSUs, net of the remittance of the participants withholding tax obligation of $4 million.
(3)The total fair value of equity settled DSU awards vested, the number of units outstanding that were nonvested, unrecognized compensation cost and the remaining recognition period have not been quantified as they relate to a minimal number of units.
As at September 30, 2024 the liability for cash settled DSU awards was $5 million based on a closing stock price of $158.37 ($5 million based on a closing stock price of $166.55 as at December 31, 2023).
Stock option awards
Options outstanding
Number of options
Weighted-average
exercise price
In millions
Outstanding at December 31, 2023 (1)
3.3
$
127.64
Granted (2)
0.4
$
166.65
Exercised
(0.4)
$
99.91
Forfeited
(0.1)
$
153.76
Outstanding at September 30, 2024 (1)(2)(3)
3.2
$
136.91
Exercisable at September 30, 2024 (1)(3)
1.8
$
122.49
(1)Stock options with a US dollar exercise price have been translated into Canadian dollars using the foreign exchange rate in effect at the balance sheet date.
(2)The grant date fair value of options granted in 2024 of $14 million ($36.55 per option) is calculated using the Black-Scholes option-pricing model. The options granted in 2024 vest over a four-year period compared to a five-year period for options granted in the years 2020 to 2023. As at September 30, 2024, total unrecognized compensation cost related to all outstanding awards was $23 million and is expected to be recognized over a weighted-average period of 3.0 years.
(3)The weighted-average term to expiration of options outstanding was 6.2 years and the weighted-average term to expiration of exercisable stock options was 4.9 years. As at September 30, 2024, the aggregate intrinsic value of in-the-money stock options outstanding amounted to $75 million and the aggregate intrinsic value of stock options exercisable amounted to $66 million.
Employee Share Investment Plan
ESIP
Number of shares
Weighted-average
share price
In millions
Unvested contributions at December 31, 2023
0.2
$
156.40
Company contributions
0.2
$
167.40
Forfeited
(0.1)
$
163.67
Vested (1)
(0.1)
$
157.91
Unvested contributions at September 30, 2024 (2)
0.2
$
163.84
(1)As at September 30, 2024, total fair value of units purchased with Company contributions that vested in 2024 was $21 million.
(2)As at September 30, 2024, total unrecognized compensation cost related to all outstanding awards was $17 million and is expected to be recognized over the next twelve months.
CN | 2024 Quarterly Review – Third Quarter 21
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
9 – Accumulated other comprehensive loss
The following tables present the changes in Accumulated other comprehensive loss by component for the three and nine months ended September 30, 2024 and 2023:
In millions
Foreign
currency
translation
Pension
and other postretirement benefit plans
Derivative instruments
Total
before tax
Income tax recovery (expense) (1)
Total
net of tax
Balance at June 30, 2024
$
(23)
$
(2,976)
$
96
$
(2,903)
$
839
$
(2,064)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)
(186)
(186)
—
(186)
Translation of US dollar debt (3)
133
133
(17)
116
Derivative instruments (4)
(15)
(15)
4
(11)
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)
14
14
(4)
10
Amortization of prior service credit
(2)
(2)
—
(2)
Amortization of gain on treasury locks
(1)
(1)
—
(1)
Other comprehensive income (loss)
(53)
12
(16)
(57)
(17)
(74)
Balance at September 30, 2024
$
(76)
$
(2,964)
$
80
$
(2,960)
$
822
$
(2,138)
In millions
Foreign
currency
translation
Pension
and other postretirement benefit plans
Derivative instruments
Total
before tax
Income tax recovery (expense) (1)
Total
net of tax
Balance at December 31, 2023
$
(171)
$
(3,003)
$
99
$
(3,075)
$
796
$
(2,279)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)
332
332
—
332
Translation of US dollar debt (3)
(237)
(237)
32
(205)
Derivative instruments (4)
(15)
(15)
4
(11)
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)
42
42
(11)
31
Amortization of prior service credit
(3)
(3)
—
(3)
Amortization of gain on treasury locks
(4)
(4)
1
(3)
Other comprehensive income (loss)
95
39
(19)
115
26
141
Balance at September 30, 2024
$
(76)
$
(2,964)
$
80
$
(2,960)
$
822
$
(2,138)
Footnotes to the tables follow on the next page.
22 CN | 2024 Quarterly Review – Third Quarter
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
In millions
Foreign
currency
translation
Pension
and other postretirement benefit plans
Derivative instruments
Total
before tax
Income tax recovery (expense) (1)
Total
net of tax
Balance at June 30, 2023
$
(157)
$
(2,671)
$
21
$
(2,807)
$
728
$
(2,079)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)
364
364
—
364
Translation of US dollar debt (3)
(275)
(275)
36
(239)
Derivative instruments
59
59
(15)
44
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)
1
1
—
1
Amortization of prior service credit
(1)
(1)
—
(1)
Other comprehensive income
89
—
59
148
21
169
Balance at September 30, 2023
$
(68)
$
(2,671)
$
80
$
(2,659)
$
749
$
(1,910)
In millions
Foreign
currency
translation
Pension
and other postretirement benefit plans
Derivative instruments
Total
before tax
Income tax recovery (expense) (1)
Total
net of tax
Balance at December 31, 2022
$
(70)
$
(2,669)
$
3
$
(2,736)
$
767
$
(1,969)
Other comprehensive income (loss) before reclassifications:
Translation of net investment (2)
17
17
—
17
Translation of US dollar debt (3)
(15)
(15)
1
(14)
Derivative instruments
77
77
(19)
58
Amounts reclassified from Accumulated other comprehensive loss:
Amortization of net actuarial loss (5)
1
1
—
1
Amortization of prior service credit
(3)
(3)
—
(3)
Other comprehensive income (loss)
2
(2)
77
77
(18)
59
Balance at September 30, 2023
$
(68)
$
(2,671)
$
80
$
(2,659)
$
749
$
(1,910)
(1)The Company releases stranded tax effects from Accumulated other comprehensive loss to Net income upon the liquidation or termination of the related item.
(2)Foreign exchange gains or losses on translation of net investment in foreign operations.
(3)Foreign exchange gains or losses on translation of US dollar-denominated debt designated as a hedge of the net investment in foreign operations. The Company designates US dollar-denominated debt of the parent company as a foreign currency hedge of its net investment in foreign operations. Accordingly, from the dates of designation, foreign exchange gains and losses on translation of the Company's US dollar-denominated debt are recorded in Accumulated other comprehensive loss, which minimizes the volatility of earnings resulting from the conversion of US dollar-denominated debt into Canadian dollars.
(4)Cumulative gains or losses of treasury locks are included in Derivative instruments. See Note 11 – Financial instruments for additional information.
(5)Total before tax reclassified to Other components of net periodic benefit income in the Consolidated Statements of Income and included in net periodic benefit income. See Note 5 – Pensions and other postretirement benefits for additional information.
CN | 2024 Quarterly Review – Third Quarter 23
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
10 – Major commitments and contingencies
Purchase commitments
As at September 30, 2024, the Company had fixed and variable commitments to purchase engineering services, locomotives, rail, information technology services and licenses, railroad cars, wheels, rail ties as well as other equipment and services with a total estimated cost of $2,593 million. Costs of variable commitments were estimated using forecasted prices and volumes.
Contingencies
In the normal course of business, the Company becomes involved in various legal actions seeking compensatory and occasionally punitive damages, including actions brought on behalf of various purported classes of claimants and claims relating to employee and third-party personal injuries, occupational disease and property damage, arising out of harm to individuals or property allegedly caused by, but not limited to, derailments or other accidents.
As at September 30, 2024, the Company had aggregate reserves for personal injury and other claims of $285 million, of which $59 million was recorded as a current liability ($311 million as at December 31, 2023, of which $51 million was recorded as a current liability).
Although the Company considers such provisions to be adequate for all its outstanding and pending claims, the final outcome with respect to actions outstanding or pending as at September 30, 2024, or with respect to future claims, cannot be reasonably determined. When establishing provisions for contingent liabilities the Company considers, where a probable loss estimate cannot be made with reasonable certainty, a range of potential probable losses for each such matter, and records the amount it considers the most reasonable estimate within the range. However, when no amount within the range is a better estimate than any other amount, the minimum amount in the range is accrued. For matters where a loss is reasonably possible but not probable, a range of potential losses cannot be estimated due to various factors which may include the limited availability of facts, the lack of demand for specific damages and the fact that proceedings were at an early stage. Based on information currently available, the Company believes that the eventual outcome of the actions against the Company will not, individually or in the aggregate, have a material adverse effect on the Company's financial position. However, due to the inherent inability to predict with certainty unforeseeable future developments, there can be no assurance that the ultimate resolution of these actions will not have a material adverse effect on the Company's results of operations, financial position or liquidity.
Environmental matters
The Company's provision for specific environmental sites is undiscounted and includes costs for remediation and restoration of sites, as well as monitoring costs. Costs related to any unknown existing or future contamination will be accrued in the period in which they become probable and reasonably estimable. Additional information relating to the Company's environmental matters is provided in Note 22 – Major commitments and contingencies to the Company's 2023 Annual Consolidated Financial Statements.
Under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (CERCLA), the Company through one of its subsidiaries was notified by the U.S. Environmental Protection Agency (EPA) on February 28, 2024 that it is a potentially responsible party (PRP), along with at least five other previously notified parties, with respect to the Matthiessen & Hegeler Zinc Company Site (Site) in LaSalle, Illinois. EPA also requested that the Company respond to certain information requests, which the Company did on June 30, 2024. The Company’s designation as a PRP is based on claims that the Company, or its predecessors, had land holdings historically that were leased to others for commercial or industrial uses that may allegedly have resulted in the disposal of hazardous substances onto the Site. Based on remedial investigations and feasibility studies previously conducted, the EPA issued a Record of Decision outlining the clean-up plan for the Site and certain off-Site areas. The Company has not accrued for any obligation related to the remediation of the Site as it has not been able to confirm to what, if any, extent it contributed to the contamination, the extent and cost of remediation and the contribution of other potentially responsible parties and their ability to pay for their obligations.
As at September 30, 2024, the Company had aggregate accruals for environmental costs of $56 million, of which $38 million was recorded as a current liability ($58 million as at December 31, 2023, of which $39 million was recorded as a current liability). The Company anticipates that the liability at September 30, 2024 will be paid out over the next five years. Based on the information currently available, the Company considers its accruals to be adequate.
24 CN | 2024 Quarterly Review – Third Quarter
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
Guarantees and indemnifications
A description of the Company's guarantees and indemnifications is provided in Note 22 – Major commitments and contingencies to the Company's 2023 Annual Consolidated Financial Statements.
As at September 30, 2024, the Company had outstanding letters of credit of $325 million ($337 million as at December 31, 2023) under the committed bilateral letter of credit facilities and $142 million ($152 million as at December 31, 2023) under the uncommitted bilateral letter of credit facilities, and surety and other bonds of $141 million ($157 million as at December 31, 2023), all issued by financial institutions with investment grade credit ratings to third parties to indemnify them in the event the Company does not perform its contractual obligations.
As at September 30, 2024, the maximum potential liability under these guarantee instruments was $608 million ($646 million as at December 31, 2023), of which $564 million ($603 million as at December 31, 2023) related to other employee benefit liabilities and workers' compensation and $44 million ($43 million as at December 31, 2023) related to other liabilities. The guarantee instruments expire at various dates between 2024 and 2025.
As at September 30, 2024, the Company had not recorded a liability with respect to guarantees and indemnifications as the Company did not expect to make any payments under its guarantees and indemnifications.
11 – Financial instruments
Derivative financial instruments
The Company uses derivative financial instruments from time to time in the management of its foreign currency and interest rate exposures. The Company has limited involvement with derivative financial instruments in the management of its risks and does not hold or issue them for trading or speculative purposes.
Foreign currency risk
As at September 30, 2024, the Company had outstanding foreign exchange forward contracts to purchase a notional value of US$1,490 million (US$1,496 million as at December 31, 2023). These outstanding contracts are at a weighted-average exchange rate of $1.35 per US$1.00 ($1.37 per US$1.00 as at December 31, 2023) with exchange rates ranging from $1.35 to $1.37 per US$1.00 ($1.34 to $1.39 per US$1.00 as at December 31, 2023). The weighted-average term of the contracts is 60 days (77 days as at December 31, 2023) with terms ranging from 14 days to 125 days (26 days to 178 days as at December 31, 2023). Changes in the fair value of foreign exchange forward contracts, resulting from changes in foreign exchange rates, are recognized in Other income (loss) in the Consolidated Statements of Income as they occur.
For the three and nine months ended September 30, 2024, the Company recorded a loss of $22 million and a gain of $53 million, respectively, related to foreign exchange forward contracts compared to gains of $50 million and $23 million, respectively, for the same periods in 2023. These gains were largely offset by the re-measurement of US dollar-denominated monetary assets and liabilities recorded in Other income (loss).
As at September 30, 2024, the fair value of outstanding foreign exchange forward contracts included in Other current assets and Accounts payable and other was $2 million and $6 million, respectively ($nil and $64 million, respectively, as at December 31, 2023).
Interest rate risk
During the third quarter of 2024, the Company entered into treasury lock agreements to hedge US Treasury benchmark rates related to expected debt issuances in 2024. The treasury locks were designated as cash flow hedging instruments with cumulative gains or losses recorded in Accumulated other comprehensive loss in derivative instruments. In conjunction with the September 18, 2024 debt issuance, the Company settled a notional US$500 million ($680 million) of treasury locks, resulting in a cumulative loss of $15 million. The cash outflows were included in operating activities in the Consolidated Statements of Cash Flows, and the loss was recorded in Accumulated other comprehensive loss and is being amortized over the term of the corresponding debt and recognized as an adjustment to interest expense on the Consolidated Statements of Income. As at September 30, 2024, there were no treasury locks outstanding ($nil as at December 31, 2023).
CN | 2024 Quarterly Review – Third Quarter 25
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
Fair value of financial instruments
The financial instruments that the Company measures at fair value on a recurring basis in periods subsequent to initial recognition are categorized into the following levels of the fair value hierarchy based on the degree to which inputs are observable:
•Level 1: Inputs are quoted prices for identical instruments in active markets
•Level 2: Significant inputs (other than quoted prices included in Level 1) are observable
•Level 3: Significant inputs are unobservable
The carrying amounts of Cash and cash equivalents and Restricted cash and cash equivalents approximate fair value. These financial instruments include highly liquid investments purchased three months or less from maturity, for which the fair value is determined by reference to quoted prices in active markets.
The carrying amounts of Accounts receivable, Other current assets and Accounts payable and other approximate fair value due to their short maturity, unless otherwise specified. The fair value of derivative financial instruments, included in Other current assets and Accounts payable and other is classified as Level 2 and is used to manage the Company's exposure to foreign currency risk and interest rate risk. The fair value is measured by discounting future cash flows using a discount rate derived from market data for financial instruments subject to similar risks and maturities.
The carrying amount of the Company's debt does not approximate fair value. The fair value is estimated based on quoted market prices for the same or similar debt instruments, as well as discounted cash flows using current interest rates for debt with similar terms, company rating, and remaining maturity. The Company classifies debt as Level 2. As at September 30, 2024, the Company's debt, excluding finance leases, had a carrying amount of $20,691 million ($18,435 million as at December 31, 2023) and a fair value of $20,258 million ($17,844 million as at December 31, 2023). The carrying amount of debt excluding finance leases exceeded the fair value due to market rates being higher than the stated coupon rates.